"When products are not tested in a diverse population, there is a reluctance to accept them as solutions," says Tonianne Lisante, a Kenvue scientific engagement manager, in a press release.
That may have just changed.
A study published in the Journal of Dermatological Treatment looked at 49 black children between the ages of 2 and 15 with mild to moderate atopic dermatitis, the most common chronic inflammatory skin disease.
They were divided into two groups: one that used 1% colloidal oatmeal cream at least twice daily for three weeks and the other that used a prescription barrier cream.
After three weeks, the children's scores on the Eczema Area and Severity Index (EASI) had improved by 1.7 and 2.3 points, respectively, with the oatmeal cream group showing the greatest improvement.
"The diverse population included in this study provided a new opportunity to conduct a sub analysis among the group of Black subjects, who we know are more effected by eczema, to help advance community health and solve for public health challenges," Lisante says in the press release.
In the colloidal oatmeal group, 100% of participants reported that the cream was appropriate for use on children, 88% said they would use the cream daily rather than occasionally, and both groups showed improvement in pruritis, skin appearance Read the Entire Article
A customized collection of grant news from foundations and the federal government from around the Web.
Social entrepreneur and co-founder of nonprofit Jolkona, Adnan Mahmud, discusses his definition of a successful social entrepreneur. He describes theĀ social entrepreneur as someone who has found the right balance between doing good while doing well.